A new method for treatment of barbiturate dependence.
D001463:Barbiturates / Q000009:adverse effects* / Q000097:blood; D002707:Chlordiazepoxide / Q000009:adverse effects; D003975:Diazepam / Q000009:adverse effects; D003932:Heroin / Q000009:adverse effects; D006801:Humans; D008620:Meprobamate / Q000009:adverse effects; D010424:Pentobarbital / Q000009:adverse effects; D010634:Phenobarbital / Q000008:administration & dosage / Q000627:therapeutic use*; D010672:Phenytoin / Q000627:therapeutic use; D012631:Secobarbital / Q000009:adverse effects; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D019966:Substance-Related Disorders / Q000188:drug therapy*
D001463:Barbiturates; D012631:Secobarbital; D010672:Phenytoin; D002707:Chlordiazepoxide; D003932:Heroin; D008620:Meprobamate; D010424:Pentobarbital; D003975:Diazepam; D010634:Phenobarbital